Molecular insights into an ancient bone disorder
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA485979 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR7692386.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 1 of 1 |
Similar Datasets
Project description:DE microRNAs between normal bone and ancient osteosarcoma
2019-06-21 | GSE118540 | GEO
Project description:Paget disease of bone (PDB) is a chronic skeletal disorder with contemporary cases characterised by one or a few affected bones in individuals over 55 years of age. PDB-like changes have been noted in archaeological remains as old as Roman although accurate diagnoses and knowledge of the natural history of ancient forms of the disease are lacking. Previous macroscopic and radiographic analyses of six skeletons from a collection of 130 excavated at Norton Priory in Cheshire, UK, and dating to late Medieval times, noted unusually extensive pathological changes resembling PDB affecting up to 75% of individual skeletons. Here we report the prevalence of the disease in the collection is also remarkably high (at least 15.8% of the adult sample) with age-at-death estimations as low as 35 years. Despite these profound phenotypic differences paleoproteomic analyses identified SQSTM1/p62 (p62), a protein central to the pathological milieu of classical PDB, as one of the few non-collagenous human sequences preserved in skeletal samples, indicating that the disorder was likely an ancient precursor of contemporary PDB. Western blotting indicated abnormal migration of ancient p62 protein, with subsequent targeted proteomic analyses detecting more than 60% of the p62 primary sequence and directing sequencing analyses of ancient DNA that excluded contemporary PDB-associated SQSTM1 mutations. Together our observations indicate the ancient p62 protein is likely modified within its C-terminal ubiquitin-associated (UBA) domain. Ancient miRNAs were also remarkably well preserved in an osteosarcoma from a skeleton with extensive disease, with miR-16 expression changes consistent with that reported in contemporary PDB-associated bone tumours. Our work demonstrates the potential of proteomics to inform diagnoses of ancient disease and supports the proposal that Medieval Norton Priory was a ‘hotspot’ for an ancient form of PDB, with unusual features presumably potentiated by as yet unidentified environmental or genetic factors.
2019-04-09 | PXD011743 | Pride
Project description:Ancient genomes reveal insights into ritual life at Chichén Itzá
| PRJEB73567 | ENA
Project description:Ancient DNA sequence quality is independent of fish bone weight
| PRJEB54658 | ENA
Project description:Isotope analyses are some of the most common analytical methods applied to ancient bone, aiding the interpretation of past diets and chronology. For this, the evaluation of “collagen” yield is a routine step that allows for the selection of the specimens that are adequate for subsequent analyses, and samples with below ~1% yield normally discarded. Additionally, during the “collagen extraction” procedure, several sample fractions are generated and subsequently discarded but could contain proteins of analytical interest. In this study we evaluated the proteome variability of different fractions generated during the “collagen extraction” process of 29 samples, and their correlation with the collagen yield. We found that these fractions contained a significant amount of both collagenous and non-collagenous protein (NCP) spectra and that these were not correlated with the collagen yield. The variety of the extracted NCPs was comparable with that normally obtained from ancient samples, and the information obtained can be used to conduct species identification, phylogenetic studies, isotopic analyses and may be used to perform radiocarbon dating on the specimens. Overall, these findings suggest that not only is there value in retaining the fractions typically discarded as waste, but that low collagen yield specimens can still yield useful information.
2021-02-08 | PXD020516 | Pride
Project description:Paget's disease of bone (PDB) is a chronic skeletal disorder that can affect one or several bones in individuals older than 55 y of age. PDB-like changes have been reported in archaeological remains as old as Roman, although accurate diagnosis and natural history of the disease is lacking. Six skeletons from a collection of 130 excavated at Norton Priory in the North West of England, which dates to medieval times, show atypical and extensive pathological changes resembling contemporary PDB affecting as many as 75% of individual skeletons. Disease prevalence in the remaining collection is high, at least 16% of adults, with age at death estimations as low as 35 y. Despite these atypical features, paleoproteomic analysis identified sequestosome 1 (SQSTM1) or p62, a protein central to the pathological milieu of PDB, as one of the few noncollagenous human sequences preserved in skeletal samples. Targeted proteomic analysis detected >60% of the ancient p62 primary sequence, with Western blotting indicating p62 abnormalities, including in dentition. Direct sequencing of ancient DNA excluded contemporary PDB-associated SQSTM1 mutations. Our observations indicate that the ancient p62 protein is likely modified within its C-terminal ubiquitin-associated domain. Ancient miRNAs were remarkably preserved in an osteosarcoma from a skeleton with extensive disease, with miR-16 expression consistent with that reported in contemporary PDB-associated bone tumors. Our work displays the use of proteomics to inform diagnosis of ancient diseases such as atypical PDB, which has unusual features presumably potentiated by yet-unidentified environmental or genetic factors.
| S-EPMC6535003 | biostudies-literature
Project description:16p11.2 Reciprocal Genomic Disorder Tissue-Specific Mouse Molecular Signatures
| PRJNA522362 | ENA
Project description:Ancient DNA provides insights into 4,000 years of resource economy across Greenland
| PRJEB55117 | ENA
Project description:The molecular grammar of protein disorder guiding genomic binding specificity
| PRJNA875916 | ENA